3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Neuroblastoma
16
Central Nervous System Neoplasms
13
Brain Neoplasms
9
Medulloblastoma
8
Rhabdoid Tumor
6
Astrocytoma
6
Sarcoma
5
Glioma
5
Oligodendroglioma
4
Lymphoma
4
Pinealoma
3
Osteosarcoma
3
Optic Nerve Glioma
3
Ependymoma
3
Testicular Neoplasms
2
Testicular Germ Cell Tumor
2
Teratoma
2
Spinal Cord Neoplasms
2
Rhabdomyosarcoma
2
Recurrence
2
Ovarian Neoplasms
2
Neuroectodermal Tumors, Primitive, Peripheral
2
Neoplasms, Germ Cell and Embryonal
2
Neoplasms
2
Kidney Neoplasms
2
Glioblastoma
2
Ganglioneuroblastoma
2
Familial ependymoma
2
Drug-Related Side Effects and Adverse Reactions
2
Choroid Plexus Neoplasms
2
Interventions
Cancer Vaccines
2
Adjuvants, Immunologic
2
veliparib
1
glutathione pegylated liposomal doxorubicin
1
etoposide phosphate
1
Trastuzumab
1
Tissue Banks
1
Modafinil
1
Etoposide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Nervous System Neoplasms
×
etoposide phosphate
×
CNS
×
Clear all
NCT05762419
2026-01-28
FUS Etoposide for DMG
Columbia University
Phase 1
Recruiting
10 enrolled